A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
Clinical trial NCT00744926 · COMPLETED
Trial details
- NCT number
- NCT00744926
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-04-01
- Enrollment
- 373
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.